Suanfarma Suanfarma

X

Find the latest Drugs in Development and Pipeline Prospector News of Pharmosa Biopharm.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Pharmosa Biopharm
Taiwan Flag
Country
Country
Taiwan
Address
Address
3F.-3, No.66, Sanchong Rd., Nangang Dist., Taipei City 11502
Telephone
Telephone
+886 227827561
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Liquidia will be responsible for development, regulatory and commercial activities of L606, an inhaled, sustained-release formulation of treprostinil being evaluated for treating PAH and pulmonary hypertension associated with interstitial lung disease, in North America.


Lead Product(s): Treprostinil Sodium

Therapeutic Area: Cardiology/Vascular Diseases Product Name: L606

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Liquidia Corporation

Deal Size: $225.0 million Upfront Cash: $10.0 million

Deal Type: Collaboration June 28, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY